Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer
Ridho Assidicky, Ünal Metin Tokat, Ibrahim Oğuzhan Tarman, Özge Saatci, Pelin G. Ersan, Umar Raza, Hasan Oğul, Yasser Riazalhosseini, Tolga Can, Özgür Şahin
Topics & Concepts
Triple-negative breast cancerBreast cancerChemotherapyMedicineOncologyCancerAlpha (finance)Internal medicineCancer researchSurgeryPatient satisfactionConstruct validityCancer, Hypoxia, and MetabolismCell Adhesion Molecules ResearchBarrier Structure and Function Studies